Hims & Hers Health Inc - Class A Stock Prediction and Forecast [HIMS]

AI-generated source summary

HIMS & HERS HEALTH INC (HIMS) shows several negative signals, including a bearish trend indicated by moving averages and a sell signal from the 3-month MACD. This suggests a potential short-term decline. Despite a recent positive trend, the stock is expected to underperform in the coming days or weeks. Key resistance levels are identified at $46.38 and $53.23. A breakthrough above these levels could signal a reversal, but current indicators point to continued weakness. The stock's recent performance includes a daily drop of 2.35% and a 3-month decline of 6.61%. Additionally, the stock's price is currently below both its 50-day and 200-day moving averages, which are at $167.08 and $152.36 respectively, indicating bearish sentiment. The volume at the last close was 99.01 million, with an average volume of 58.18 million, suggesting increased investor interest. The stock is currently trading at $44.39, with support at $43.96 and resistance at $49.78. The stock is exhibiting high volatility.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   04 Nov 2025, 04:47 UTC

   The analyst published the original source item.

2. First prediction resolved

   04 Nov 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   04 Nov 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:11 UTC

   Tahlil Plus began monitoring the extracted predictions.